122 related articles for article (PubMed ID: 22889800)
1. Gummatous syphilis of the adrenal gland.
Scheurkogel MM; Tim J; Jeurissen FJ; Quarles van Ufford HM
Clin Nucl Med; 2012 Sep; 37(9):e231-3. PubMed ID: 22889800
[TBL] [Abstract][Full Text] [Related]
2. Adrenal epithelioid angiosarcoma metastatic to the epicardium: diagnosis by 18F-FDG PET/CT.
Derlin T; Clauditz TS; Habermann CR
Clin Nucl Med; 2012 Sep; 37(9):914-5. PubMed ID: 22889791
[TBL] [Abstract][Full Text] [Related]
3. A rare case of solitary fibrous tumor of the adrenal gland detected by (18)F-FDG PET/CT.
Treglia G; Oragano L; Fadda G; Raffaelli M; Lombardi CP; Castaldi P; Rufini V
Clin Nucl Med; 2014 May; 39(5):475-7. PubMed ID: 23640229
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT imaging of extrapulmonary small cell carcinoma of the adrenal gland.
Dong A; Zuo C; Wang Y
Clin Nucl Med; 2013 Nov; 38(11):e407-10. PubMed ID: 23531740
[TBL] [Abstract][Full Text] [Related]
5. Gallbladder carcinoma metastasizing to adrenal gland: a rare site demonstrated with (18)F-FDG PET/CT.
Sahoo MK; Sharma P; Suman S; Jain TK; Bal C; Kumar R
Clin Nucl Med; 2014 Feb; 39(2):184-5. PubMed ID: 23856827
[TBL] [Abstract][Full Text] [Related]
6. Gummatous Syphilis Mimicking Malignant Bone Tumor on FDG PET/CT.
Wang LJ; Wu HB; Zhou WL; Yu SR; Wang QS
Clin Nucl Med; 2019 Apr; 44(4):313-316. PubMed ID: 30672757
[TBL] [Abstract][Full Text] [Related]
7. Generalized lymphadenopathy and 18-fluorine fluorodeoxyglucose positron emission tomography/computed tomography: targeting diagnostic intervention, characterizing disease extent, and assessing treatment efficacy in syphilis.
Ranganath P; Kapila R; Vadehra V; Wang Q; Capitle E; Ghesani N
Sex Transm Dis; 2015 Feb; 42(2):68-70. PubMed ID: 25585063
[TBL] [Abstract][Full Text] [Related]
8. Neurosyphilitic gumma on F18-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography: an old disease investigated with a new technology.
Lin M; Darwish BS; Chu J
J Clin Neurosci; 2009 Mar; 16(3):410-2. PubMed ID: 19138854
[TBL] [Abstract][Full Text] [Related]
9. The value of adding (18)F-FDG PET/CT to adrenal protocol CT for characterizing adrenal metastasis (≥ 10 mm) in oncologic patients.
Park SY; Park BK; Kim CK
AJR Am J Roentgenol; 2014 Feb; 202(2):W153-60. PubMed ID: 24450697
[TBL] [Abstract][Full Text] [Related]
10. Importance of adrenal incidentaloma in patients with a history of malignancy.
Frilling A; Tecklenborg K; Weber F; Kühl H; Müller S; Stamatis G; Broelsch C
Surgery; 2004 Dec; 136(6):1289-96. PubMed ID: 15657589
[TBL] [Abstract][Full Text] [Related]
11. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
12. Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.
Kim YI; Cheon GJ; Paeng JC; Cho JY; Kang KW; Chung JK; Kim EE; Lee DS
Nucl Med Commun; 2014 Jun; 35(6):606-12. PubMed ID: 24598843
[TBL] [Abstract][Full Text] [Related]
13. Pituitary FDG uptake in a patient of lung cancer with bilateral adrenal metastases causing adrenal cortical insufficiency.
Weng JH; Lee JK; Wu MF; Shen CY; Kao PF
Clin Nucl Med; 2011 Aug; 36(8):731-2. PubMed ID: 21716036
[TBL] [Abstract][Full Text] [Related]
14. Abdominal aortic aneurysm with bony erosion mimicking recurrent non-Hodgkin lymphoma on FDG PET/CT.
Kim DW; Kim WH; Kim CG
Clin Nucl Med; 2013 May; 38(5):e233-5. PubMed ID: 23143046
[TBL] [Abstract][Full Text] [Related]
15. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
[TBL] [Abstract][Full Text] [Related]
17. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
Blake MA; Slattery JM; Kalra MK; Halpern EF; Fischman AJ; Mueller PR; Boland GW
Radiology; 2006 Mar; 238(3):970-7. PubMed ID: 16505394
[TBL] [Abstract][Full Text] [Related]
18. Primary Adrenal Sarcomatoid Carcinoma Detected by 18F-FDG PET/CT.
Zhang J; Gong W; Zhang W; Zhang C; Zhang G
Clin Nucl Med; 2022 May; 47(5):433-434. PubMed ID: 35067543
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT.
Kim BS; Lee JD; Kang WJ
Ann Nucl Med; 2015 Apr; 29(3):276-83. PubMed ID: 25480483
[TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG PET/CT of adrenal lesions.
Dong A; Cui Y; Wang Y; Zuo C; Bai Y
AJR Am J Roentgenol; 2014 Aug; 203(2):245-52. PubMed ID: 25055255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
